Ledger.

MD and CEO, Imugene

Leslie Chong

Coverage

Stories naming Leslie Chong. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Grant $4.5m

Manufacturing news briefs — stories you might have missed

Manufacturing briefs: XRF Scientific posts record results, Universal Biosensors receives an R&D tax rebate, Imugene and SMC appoint executives, FWPA promotes forestry in a new campaign, and AGL agrees a Loy Yang transition fund.

@AuManufacturing Mon 21 Aug 2023 Universal BiosensorsAGLCelularityForest & Wood Products Australia (FWPA)ImugeneModernaMonash UniversitySMC Corporation AustraliaUniversity of ColoradoVictorian GovernmentXRF ScientificAustralian GovernmentAdam DovileDr Bradley GloverEd HusicLeslie ChongLily D'AmbrosioSarah DowneySimon McDonaldVance Stazzonelli
Unnamed stage $10m

Brandon Capital, Uniseed back cancer biotech start-up in $10m funding

Melbourne cancer immunotherapy startup Currus Biologics, spun out of Peter MacCallum, raised $10 million led by the Brandon Capital-managed Medical Research Commercialisation Fund with Uniseed, to advance its BEAT technology toward human trials.

Brandon Capital portfolio Mon 28 Jun 2021 Currus BiologicsBrandon CapitalChimeric TherapeuticsImugeneMedical Research Commercialisation Fund (MRCF)Peter MacCallum Cancer CentreUniseedDr Clare SlaneyLeslie ChongProfessor Michael KershawSam Cobb

Also Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·SmartCompany·Startup Daily·SmartCompany·Startup Daily

Something wrong? Tell us